InDex Pharmaceuticals’ SEK 533 Million Rights Issue

Setterwalls advised InDex Pharmaceuticals Holding AB on the deal. InDex Pharmaceuticals Holding AB, listed on Nasdaq First North Growth Market, announced a rights issue of approximately…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here